Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein
- PMID: 11590151
- DOI: 10.1074/jbc.M106777200
Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein
Abstract
alpha-Synuclein (alpha S) is a pre-synaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease (PD). Two autosomal dominant missense mutations in the alpha S gene are associated with early onset PD. Because alpha S is found in an aggregated fibrillar form in the Lewy body deposits characteristic of Parkinson's patients, aggregation of the protein is believed to be related to its involvement in the disease process. The wild type (WT) and early onset mutants A30P and A53T display diverse in vitro aggregation kinetics even though the gross physicochemical and morphological properties of the mutants are highly similar. We used high resolution solution NMR spectroscopy to compare the structural and dynamic properties of the A53T and A30P mutants with those of WT alpha S in the free state. We found that the A30P mutation disrupts a region of residual helical structure that exists in the WT protein, whereas the A53T mutation results in a slight enhancement of a small region around the site of mutation with a preference for extended conformations. Based on these results and on the anticipated effects of these mutations on elements of secondary structure, we proposed a model of how these two PD-linked mutations influence alpha S fibril formation that is consistent with the documented differences in the fibrillization kinetics of the two mutants.
Similar articles
-
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.Biochemistry. 2004 Apr 27;43(16):4810-8. doi: 10.1021/bi036135+. Biochemistry. 2004. PMID: 15096050
-
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.Biochemistry. 2001 Sep 25;40(38):11604-13. doi: 10.1021/bi010616g. Biochemistry. 2001. PMID: 11560511
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Alpha-synuclein aggregation and neurodegenerative diseases.J Alzheimers Dis. 2003 Apr;5(2):139-48. doi: 10.3233/jad-2003-5208. J Alzheimers Dis. 2003. PMID: 12719631 Review.
-
Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.FEBS Lett. 2002 Jul 3;522(1-3):9-13. doi: 10.1016/s0014-5793(02)02883-1. FEBS Lett. 2002. PMID: 12095610 Review.
Cited by
-
Unravelling the effect of N(ε)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of α-synuclein.Chem Sci. 2020 Mar 10;11(12):3332-3344. doi: 10.1039/d0sc00906g. Chem Sci. 2020. PMID: 34122841 Free PMC article.
-
Investigation of the Polymeric Properties of α-Synuclein and Comparison with NMR Experiments: A Replica Exchange Molecular Dynamics Study.J Chem Theory Comput. 2012 Oct 9;8(10):3929-3942. doi: 10.1021/ct300241t. Epub 2012 Jun 5. J Chem Theory Comput. 2012. PMID: 23162382 Free PMC article.
-
Disruption of protein quality control in Parkinson's disease.Cold Spring Harb Perspect Med. 2012 May;2(5):a009423. doi: 10.1101/cshperspect.a009423. Cold Spring Harb Perspect Med. 2012. PMID: 22553500 Free PMC article. Review.
-
Synaptic vesicle mimics affect the aggregation of wild-type and A53T α-synuclein variants differently albeit similar membrane affinity.Protein Eng Des Sel. 2019 Dec 13;32(2):59-66. doi: 10.1093/protein/gzz021. Protein Eng Des Sel. 2019. PMID: 31566224 Free PMC article.
-
Alpha-synuclein: stable compact and extended monomeric structures and pH dependence of dimer formation.J Am Soc Mass Spectrom. 2004 Oct;15(10):1435-43. doi: 10.1016/j.jasms.2004.08.003. J Am Soc Mass Spectrom. 2004. PMID: 15465356
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous